Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Inositol Hexaphosphate (IP6) and Colon Cancer: From Concepts and First Experiments to Clinical Application.

Ivana Vucenik^1,2, Ana Druzijanic³, Nikica Druzijanic⁴

¹Department of Medical and Research Technology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.

Molecules (Basel, Switzerland)

|December 18, 2020

Summary

Related Concept Videos

Phosphoinositides and PIPs

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

IP6: From Seeds to Science-A Natural Compound's Path to Clinical Promise.

Biomolecules·2025

Same author

Increased risk of mild cognitive impairment is associated with severe periodontitis: A cross-sectional study.

Journal of periodontology·2025

Same author

Inositol Hexaphosphate in Bone Health and Disease.

Biomolecules·2024

Same author

Analysis and comparison of tooth wear in late antiquity and early middle age in populations that lived in continental and coastal Croatia using digitized VistaMetrix method.

The Journal of forensic odonto-stomatology·2024

Same author

<sc>d</sc>-Chiro-Inositol in Clinical Practice: A Perspective from the Experts Group on Inositol in Basic and Clinical Research (EGOI).

Gynecologic and obstetric investigation·2024

Same author

Serum Concentration of Vitamin D in Patients with Oral Lichen Planus.

Acta stomatologica Croatica·2023

Inositol hexaphosphate (IP6) and myo-inositol (Ins) show significant anticancer properties. The combination of IP6 + Ins demonstrates enhanced efficacy in cancer treatment and improves patient quality of life.

Area of Science:

Oncology
Nutritional Science
Cell Biology

Background:

Inositol hexaphosphate (IP6) and myo-inositol (Ins) are naturally occurring compounds found in plants and mammalian cells.
IP6 has demonstrated broad-spectrum anticancer activity across various experimental models over several decades.
These compounds play roles in regulating cellular functions and possess antioxidant properties.

Purpose of the Study:

To review the historical experimental findings on IP6 in colon cancer research.
To present clinical studies investigating the efficacy of IP6 + Ins in cancer patients.
To evaluate the potential of IP6 + Ins as an adjuvant or alternative cancer therapy.

Main Methods:

Review of early experimental studies on IP6 in colon cancer models.

Keywords:

cancer prevention cancer treatment clinical observations colon cancer molecular interactions phytic acid

Related Experiment Videos

Analysis of clinical trials involving IP6 + Ins in cancer patients.

Examination of molecular targets, immune enhancement, and antioxidant effects of IP6.

Main Results:

IP6 reduces cancer cell proliferation, induces apoptosis and differentiation, and reverts malignant cells to a normal phenotype.
The combination of IP6 + Ins shows superior anticancer effects compared to Ins alone.
Clinical studies indicate that IP6 + Ins enhances chemotherapy, controls metastases, and improves quality of life in cancer patients.

Conclusions:

IP6 and its combination with Ins exhibit significant anticancer potential.
IP6 + Ins shows promise as an adjuvant therapy to conventional chemotherapy.
Emerging data suggest IP6 + Ins could serve as an alternative treatment strategy for cancer.